Propanc Biopharma (PPCB) Stock Price, Quote, News & History

Key Statistics

Open

$3.55

Volume / Avg.

65.63M / 3.75M

Day Range

$2.82 - $4.13

52 Wk Range

0.95 - 85.50

Market Cap

$6.13M

P/E Ratio

0.00

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

2.76%

Days to Cover

Recent Propanc Biopharma Inc News

Nasdaq Surges 200 Points; Nvidia Posts Upbeat Q2 Results

US stocks traded higher with Nasdaq up 200 points. Dow down 0.01%, Nasdaq up 0.77%, and S&P 500 up 0.27%. Tech shares rose 2.2% while consumer staples fell 1.1%. Nvidia reported strong earnings. Propanc Biopharma up 211%, VolitionRX up 86%, Mint Incorporation up 74%, Alpha Modus down 25%, Change Agents down 29%, and Xiao-I down 21%.

Avi Kapoor

Why Friedman Industries Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket

Friedman Industries Inc (NASDAQ: FRD) rose in pre-market trading after posting strong Q4 earnings. Other gainers include BYAH, VSME, ADTX, EDHL, GMM, HKIT, RKTO, ASYS, and PWRL. Losers include GELS, NTCL, ZNB, SMSI, and NEPT.

Avi Kapoor

Crude Oil Edges Higher; Driven Brands Posts Upbeat Earnings

US stocks rise with Nasdaq up 150 points. Dow up 0.54%, Nasdaq up 0.63%, S&P 500 up 0.26%. Industrials and Enliven Therapeutics lead gains. Dana Inc and Oracle Corp down. Oil up 0.7%, gold down 0.7%. European and Asian markets mixed. Initial jobless claims and producer prices higher than expected.

Avi Kapoor

Dow Jumps Over 250 Points; US Initial Jobless Claims Rise

US stocks up, Dow gains 250 pts. Dow up 0.58% while NASDAQ up 0.67%. Materials shares jump 1.5%, communication services down 1.3%. Jobless claims up.

Avi Kapoor

Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-4.17M

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

4.55M

Free Cash Flow (TTM)

-4.18M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

368.49K

Valuation Metrics

Enterprise Value

$3.57M

PE Ratio (TTM)

0.00

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

0.25

Earnings Yield % (TTM)

53317.76%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$4.31

Company Debt

Total Debt

$520.28K

LT Debt

LT Debt Issuance (TTM)

$77.55K

LT Debt Repayment (TTM)

Total Cash

$443.70K

Debt to Equity

0.06

Issuance of Debt (TTM)

-$91.65K

Repayment of Debt (TTM)

-$1.07M

Key Statistics

Open

$3.55

Volume / Avg.

65.63M / 3.75M

Day Range

$2.82 - $4.13

52 Wk Range

0.95 - 85.50

Market Cap

$6.13M

P/E Ratio

0.00

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

2.76%

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

PPCB

ABBV

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

PPCB

ABBV

FAQ

How do I buy Propanc Biopharma (PPCB) stock?

You can purchase shares of Propanc Biopharma (NASDAQ:PPCB) through any online brokerage.

View our list of the best stock brokerages

Who are Propanc Biopharma (PPCB) competitors?

Other companies in Propanc Biopharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

What is the forecast, or price target, for Propanc Biopharma (PPCB) stock?

There is no analysis for Propanc Biopharma to provide a consensus price target.

What is the current price for Propanc Biopharma (PPCB)?

The stock price for Propanc Biopharma (NASDAQ: PPCB) is $2.69 last updated August 27, 2026 at 10:29 AM EDT.

Does Propanc Biopharma (PPCB) pay a dividend?

There are no upcoming dividends for Propanc Biopharma.

When is Propanc Biopharma (NASDAQ:PPCB) reporting earnings?

Propanc Biopharma does not have any upcoming earnings scheduled.

Is Propanc Biopharma (PPCB) going to split?

There is no upcoming split for Propanc Biopharma.

What sector and industry does Propanc Biopharma (PPCB) operate in?

Propanc Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Benzinga

Benzinga

Propanc Biopharma Inc (PPCB) Stock Price, Quote, News & History

Key Statistics

Recent Propanc Biopharma Inc News

Nasdaq Surges 200 Points; Nvidia Posts Upbeat Q2 Results

Why Friedman Industries Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket

Crude Oil Edges Higher; Driven Brands Posts Upbeat Earnings

Dow Jumps Over 250 Points; US Initial Jobless Claims Rise

Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket

Financials

Cash Flows

Valuation Metrics

Company Debt

Key Statistics

About

Edge Rankings

Stock Score Locked: Want to See it?

Compare

FAQ

How do I buy Propanc Biopharma (PPCB) stock?

Who are Propanc Biopharma (PPCB) competitors?

What is the forecast, or price target, for Propanc Biopharma (PPCB) stock?

What is the current price for Propanc Biopharma (PPCB)?

Does Propanc Biopharma (PPCB) pay a dividend?

When is Propanc Biopharma (NASDAQ:PPCB) reporting earnings?

Is Propanc Biopharma (PPCB) going to split?

What sector and industry does Propanc Biopharma (PPCB) operate in?